Merck & Co., Inc. (MRK)
111.38
-2.03
(-1.79%)
USD |
NYSE |
May 15, 16:00
111.25
-0.13
(-0.12%)
Pre-Market: 09:05
Merck EPS Diluted (Quarterly) : -1.715 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Pfizer Inc. | 0.4688 |
| Bristol Myers Squibb Co. | 1.308 |
| Terns Pharmaceuticals, Inc. (DELISTED) | -0.2395 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.243B |
| Revenue (Quarterly) | 16.20B |
| Total Expenses (Quarterly) | 20.44B |
| Enterprise Value | 318.49B |
| Gross Profit Margin (Quarterly) | 71.98% |
| Profit Margin (Quarterly) | -26.19% |
| Earnings Yield | 3.19% |
| Operating Earnings Yield | 6.49% |
| Normalized Earnings Yield | 4.632 |